<p>IC<sub>50</sub> values of TKIs against parental and ERL-resistant NSCLC cell lines.</p
<p>IC<sub>50</sub> values (µM) for TP421 and close structural analogs in pancreatic cancer cell line...
<p>IC<sub>50</sub> values of compounds MP5-F9, MP5-G9, and CA4 in various cancerous cell lines.</p
<p>IC<sub>50</sub> values (in mM) of DHCA on colon and cervical cancer cell lines.</p
<p>IC<sub>50</sub> of RTKIs and Combinations for Parental and Resistant NSCLC cell lines.</p
<p>IC<sub>50</sub> of RTKIs for NSCLC cell lines with and without T790M mutation.</p
<p>A) Representative dose-effect curve plots of HCC827 and HCC4006 parental cell lines to the indica...
<p>IC<sub>50</sub> values of native pac, pac-MNPs and lec-pac-MNPs in three leukemia cell lines.</p
<p>Dm<sub>50</sub> of single agent and drugs combination for parental and ERL-resistant NSCLC cell l...
<p>The IC<sub>50</sub> values of the kinase inhibitors towards B lymphoma cell lines and PBMCs are s...
<p>IC<sub>50</sub> values of G503 on cancer cell lines and normal cell lines.</p
<p>The IC<sub>50</sub> values of tested compounds towards different cell lines.</p
<p>EC<sub>50</sub> values and cross-resistance (R) indices of PRM-A100 and parental cell lines.</p
<p>IC<sub>50</sub> values and gene mutation status of five lung cancer cell lines.</p
<p>HCC827, HCC827/GR and HCC827/ER2 cells were treated with the indicated concentrations of gefitini...
<p>IC50 for treatment with erlotinib, gefitinib or vandetanib in parental CALU-3 and HCT116 cell lin...
<p>IC<sub>50</sub> values (µM) for TP421 and close structural analogs in pancreatic cancer cell line...
<p>IC<sub>50</sub> values of compounds MP5-F9, MP5-G9, and CA4 in various cancerous cell lines.</p
<p>IC<sub>50</sub> values (in mM) of DHCA on colon and cervical cancer cell lines.</p
<p>IC<sub>50</sub> of RTKIs and Combinations for Parental and Resistant NSCLC cell lines.</p
<p>IC<sub>50</sub> of RTKIs for NSCLC cell lines with and without T790M mutation.</p
<p>A) Representative dose-effect curve plots of HCC827 and HCC4006 parental cell lines to the indica...
<p>IC<sub>50</sub> values of native pac, pac-MNPs and lec-pac-MNPs in three leukemia cell lines.</p
<p>Dm<sub>50</sub> of single agent and drugs combination for parental and ERL-resistant NSCLC cell l...
<p>The IC<sub>50</sub> values of the kinase inhibitors towards B lymphoma cell lines and PBMCs are s...
<p>IC<sub>50</sub> values of G503 on cancer cell lines and normal cell lines.</p
<p>The IC<sub>50</sub> values of tested compounds towards different cell lines.</p
<p>EC<sub>50</sub> values and cross-resistance (R) indices of PRM-A100 and parental cell lines.</p
<p>IC<sub>50</sub> values and gene mutation status of five lung cancer cell lines.</p
<p>HCC827, HCC827/GR and HCC827/ER2 cells were treated with the indicated concentrations of gefitini...
<p>IC50 for treatment with erlotinib, gefitinib or vandetanib in parental CALU-3 and HCT116 cell lin...
<p>IC<sub>50</sub> values (µM) for TP421 and close structural analogs in pancreatic cancer cell line...
<p>IC<sub>50</sub> values of compounds MP5-F9, MP5-G9, and CA4 in various cancerous cell lines.</p
<p>IC<sub>50</sub> values (in mM) of DHCA on colon and cervical cancer cell lines.</p
DOI
Add to ORKG